Stacy Cline Amin was quoted in Advisory Board’s coverage of Robert Califf returning as commissioner of the U.S. Food and Drug Administration.
The Senate Health, Education, Labor, and Pensions committee said it will schedule a hearing on Califf’s nomination “as soon as possible.” However, according to Stacy, the nomination is unlikely to receive a vote by the end of the year.
Read the full article.